Últimas noticias sobre Apyx Medical (NASDAQ:APYX) Bolsa

Apyx Medical

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Bovie Medical

Apyx Medical Corp

Earnings

Earnings Misses

News

Fresh Del Monte Produce Q1 Adj. EPS $0.63 Misses $0.68 Estimate, Sales $1.10B Miss $1.11B Estimate

Biotech

General

PBYI

Puma Biotechnology And Er-Kim Sign Distribution Agreement For NERLYNX In Breast Cancer Patients; Er-Kim Will Be Distribution Partner For NERLYNX in Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Russia, Tajikistan, Turkmenistan, and Uzbekistan.

Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.05) by 120 percent. This is a 103.57 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $1.29 billion which missed the analyst consensus estimate of $1.34 billion by 3.49 percent. This is a 2.71 percent decrease over sales of $1.33 billion the same period last year.

Earnings Beats

LINE

Lineage Q1 GAAP EPS $0.01 Beats $(0.05) Estimate, Sales $1.29B Miss $1.34B Estimate

Guidance

GNRC

Generac Lowers FY25 Revenue Growth Guidance From 3% - 7% To Flat - 7%

Jones Trading analyst Jason Weaver reiterates Orchid Island Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORC#NYSE">ORC</a>) from Hold to Hold.

Reiteration

Analyst Ratings

Jones Trading Reiterates Hold on Orchid Island Capto Hold

DUOL

Duolingo Announced The Launch Of 148 New Language Courses, More Than Doubling Its Current Offering And Marking The Largest Expansion Of Content In The Company's History

Humana Q1 Adj. EPS $11.58 Beats $10.07 Estimate, Sales $32.11B Miss $32.22B Estimate

Aon Released Findings From A Multi-year Study Of U.S. Commercial Health Claims Data For More Than 50 Million Commercially Insured Lives And Highlights A Significant Opportunity To Reduce Healthcare Costs For Employers And Enhance Overall Workforce Health Through A Comprehensive Obesity Management Program That Includes Glp-1 Medications

Foraco Intl (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FAR#TSX">FAR</a>) reported quarterly earnings of $0.01 per share. This is a 83.33 percent decrease over earnings of $0.09 per share from the same period last year. The company reported $55.01 million in sales this quarter. This is a 28.64 percent decrease over sales of $77.09 million the same period last year.

TSX:FAR

Foraco Intl Q1 EPS $0.01 Down From $0.09 YoY, Sales $55.01M Down From $77.09M YoY

Generac Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNRC#NYSE">GNRC</a>) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $0.97 by 29.9 percent. This is a 43.18 percent increase over earnings of $0.88 per share from the same period last year. The company reported quarterly sales of $942.12 million which beat the analyst consensus estimate of $919.25 million by 2.49 percent. This is a 5.94 percent increase over sales of $889.27 million the same period last year.

Generac Hldgs Q1 Adj. EPS $1.26 Beats $0.97 Estimate, Sales $942.12M Beat $919.25M Estimate

Constellium (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSTM#NYSE">CSTM</a>) reported quarterly earnings of $0.26 per share which met the analyst consensus estimate. This is a 85.71 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $1.98 billion which missed the analyst consensus estimate of $2.01 billion by 1.66 percent. This is a 5.27 percent increase over sales of $1.88 billion the same period last year.

CSTM

Constellium Q1 EPS $0.26, Inline, Sales $1.98B Miss $2.01B Estimate

International Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IP#NYSE">IP</a>) reported quarterly earnings of $0.23 per share which missed the analyst consensus estimate of $0.36 by 36.11 percent. This is a 35.29 percent increase over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $5.90 billion which missed the analyst consensus estimate of $6.25 billion by 5.58 percent. This is a 27.75 percent increase over sales of $4.62 billion the same period last year.

International Paper Q1 Adj. EPS $0.23 Misses $0.36 Estimate, Sales $5.90B Miss $6.25B Estimate

SiteOne Landscape Supply (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SITE#NYSE">SITE</a>) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.47) by 29.79 percent. This is a 41.86 percent decrease over losses of $(0.43) per share from the same period last year. The company reported quarterly sales of $939.40 million which beat the analyst consensus estimate of $931.99 million by 0.79 percent. This is a 3.82 percent increase over sales of $904.80 million the same period last year.

SITE

SiteOne Landscape Supply Q1 EPS $(0.61) Misses $(0.47) Estimate, Sales $939.40M Beat $931.99M Estimate

Stanley Black & Decker Q1 Adj. EPS $0.75 Beats $0.66 Estimate, Sales $3.74B Beat $3.69B Estimate

Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) CEO Satya Nadella disclosed that artificial intelligence is now writing up to 30% of the tech giant&#8217;s code, signaling a fundamental shift in software development as AI tools reshape how tech companies build their products.
What Happened: Nadella said on Tuesday that AI now writes between 20-30% of the company&#8217;s code base, during a conversation with Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) CEO Mark Zuckerberg at Meta&#8217;s inaugural LlamaCon AI developer event in Menlo Park, California.
&#8220;I&#8217;d say maybe 20%, 30% of the code that is inside of our repos today and some of our projects are probably all written by software,&#8221; Nadella stated during the public discussion.
When asked about Meta&#8217;s AI code generation, Zuckerberg indicated his company is building an AI model designed to create future versions of Meta&#8217;s Llama models, predicting that &#8220;maybe half the development is going to be done by AI, as opposed to people&#8221; within the next year.
Both companies employ tens of thousands of software developers but are increasingly turning to AI for coding tasks. This trend extends beyond tech giants, with Google CEO Sundar Pichai previously reporting that more than 25% of new code at Google is AI-generated. See Also: <a href="https://www.benzinga.com/markets/25/04/45092503/jim-cramer-says-stockholders-are-not-just-arrogant-rich-people-as-markets-slide-over-5-amid-trade-war-slams-trump-tariffs-bidens-hostility-toward-business">Jim Cramer Says Stockholders Are &#8216;Not Just Arrogant Rich People&#8217; As Markets Slide Over 5% Amid Trade War—Slams Trump Tariffs, Biden&#8217;s Hostility Toward Business</a> Why It Matters: The revelations come as Microsoft continues <a href="https://www.benzinga.com/news/25/03/44066026/satya-nadella-says-ai-agents-will-replace-knowledge-work-but-theres-one-role-humans-will-always-need-to-play">expanding its AI capabilities</a> across its product suite while distinguishing between &#8220;knowledge work&#8221; and &#8220;knowledge workers&#8221; in its corporate philosophy. Nadella has emphasized that AI will transform how cognitive labor is performed without necessarily replacing human workers, comparing the shift to how spreadsheets revolutionized accounting or email transformed communication.
This integration of AI into development processes follows Microsoft&#8217;s recent launch of &#8220;Computer Use,&#8221; a new tool within <a href="https://www.benzinga.com/25/04/44831264/microsoft-debuts-computer-use-tool-for-copilot-studio-ceo-satya-nadella-says-anyone-can-build-agents-that-take-action-on-the-ui-across-desktop-and-web-apps">Copilot Studio </a>that enables AI agents to perform tasks in desktop and web applications by directly interacting with user interfaces without requiring APIs. 
The tool represents part of Microsoft&#8217;s growing AI business, which Nadella recently announced has surpassed $13 billion in annual revenue, growing 175% year-over-year.
Meanwhile, Meta has reportedly <a href="https://www.benzinga.com/25/03/44452879/meta-profits-from-llama-ai-models-despite-denials-court-filing-reveals">been monetizing its Llama AI models</a> through revenue-sharing agreements with host businesses, according to an unredacted court filing in the copyright lawsuit Kadrey v. Meta. Read Next: 
<ul>
<li><a href="https://www.benzinga.com/tech/25/04/45091974/snapchats-my-ai-once-controversial-sees-55-year-over-year-growth-in-daily-active-users-ceo-evan-spiegel-says-augmented-reality-is-the-ideal-interface">Snapchat&#8217;s My AI, Once Controversial, Sees 55% Year-Over-Year Growth In Daily Active Users: CEO Evan Spiegel Says, &#8216;Augmented Reality Is The Ideal Interface&#8217;</a></li>
</ul>
Image Via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Markets

Tech

MSFT

Satya Nadella Says AI Now Writes 30% Of Microsoft's Code — Mark Zuckerberg Predicts Half Of Meta's Future Development Will Be Done by AI

Lineage To Acquire Tyson Foods Cold Storage Warehouses, Invest $1B In U.S. Expansion And Automation Push

WestPark Capital analyst Curtis Shauger reiterates Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Buy and maintains $320 price target.

Price Target

WestPark Capital Reiterates Buy on Salesforce, Maintains $320 Price Target

Needham analyst Bernie McTernan reiterates Beyond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) from Hold to Hold.

BYON

Needham Reiterates Hold on Beyondto Hold

Anthony Scaramucci, founder and managing partner of SkyBridge Capital, is a widely known Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) advocate who routinely uses his social reach and public platforms to promote the leading cryptocurrency.&nbsp;
However, he was not drawn to Bitcoin from the get-go. An intriguing development during his time in the White House impacted his ideas, bringing him closer to the asset.
What happened: Scaramucci served as the White House Communications Director <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44602870/anthony-scaramucci-hates-it-when-trump-pumps-his-own-coin-but-loves-the-presidents-bitcoin-moves-this-complex-crypto-relationship-decoded">for a brief 11-day stint</a> during Trump's last tenure. About five to six years ago, he had heard about Bitcoin, but back then, he found it nonsensical, according to a Fortune <a href="https://fortune.com/2025/03/12/anthony-scaramucci-crypto-trump-tariffs-bitcoin-canada-treasury-price/">report</a> that cited his statement at the Abundance360 summit earlier in March.
Scaramucci remembered that the then-Treasury Secretary Steve Mnuchin and a couple of officials from the Federal Reserve had come to discuss Bitcoin and blockchain technology at the Oval Office.
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/25/04/45091619/paypal-says-its-moving-quickly-on-crypto-stablecoinfintech-giant-partners-with-coinbase-to-boost-pyusd">PayPal CEO Says &#8216;Moving Quickly&#8217; To Bring Crypto, Stablecoin Benefits To Users — Fintech Giant Partners With Coinbase To Boost Solana-based PYUSD</a>
While he was fired from service a few days later, he became fascinated by Bitcoin and began extensive research into the cryptocurrency. He soon began investing in Bitcoin via his hedge fund and revealed at the summit that Bitcoin accounted for over 70% of his portfolio.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Our speakers at <a href="https://twitter.com/Abundance360?ref_src=twsrc%5Etfw">@Abundance360</a> shared their portfolio % of Bitcoin: <a href="https://twitter.com/Scaramucci?ref_src=twsrc%5Etfw">@Scaramucci</a>: 70% <a href="https://twitter.com/billbarX?ref_src=twsrc%5Etfw">@BillbarX</a>: 100% <a href="https://twitter.com/LynAldenContact?ref_src=twsrc%5Etfw">@LynAldenContact</a>: 50% I'm at 50%. (This is not investment advice)
&mdash; Peter H. Diamandis, MD (@PeterDiamandis) <a href="https://twitter.com/PeterDiamandis/status/1899689647783178319?ref_src=twsrc%5Etfw">March 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The conviction is so strong that Scaramucci even <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41643366/missed-jumping-on-the-bitcoin-bandwagon-anthony-scaramucci-says-its-not-too-late-to-climb-">wrote a book</a> about Bitcoin called &#8220;The Little Book of Bitcoin,"&nbsp; a guide to understanding the financial implications of digital asset technology.
He has previously dubbed Bitcoin a "digital store of value" and predicted it could <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42024635/scaramucci-trumps-crypto-support-could-push-bitcoin-to-150k">surge to $150,000</a> if the regulatory issues are solved.
Price Action: At the time of writing, Bitcoin was exchanging hands at $94,806.22, down 0.21% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/04/45090666/nuclear-armed-india-pakistan-heading-for-war-polymarket-bettors-think-yes-amid-pak-ministers-imminent-attack-remark">Nuclear-Armed India, Pakistan Heading For Conflict Again? Polymarket Bettors Think Yes Amid Pak Minister&#8217;s &#8216;Imminent&#8217; Attack Remark</a></li>
</ul>
Photo Courtesy: Al Teich On Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Anthony Scaramucci Wasn't Keen On Bitcoin Initially, But The Eureka Moment Came During His Short White House Tenure Under Trump

Needham analyst Serge Belanger reiterates MoonLake (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) with a Buy and maintains $66 price target.

MLTX

Needham Reiterates Buy on MoonLake, Maintains $66 Price Target

IPOs

Press Releases

Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Health Care

Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference

Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures

Comments

Apyx Medical

Noticias

Últimas noticias sobre Apyx Medical (NASDAQ:APYX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL